ATOMERA INC (ATOM)

US04965B1008 - Common Stock

4.5  +0.05 (+1.12%)

After market: 4.55 +0.05 (+1.11%)

Fundamental Rating

3

Overall ATOM gets a fundamental rating of 3 out of 10. We evaluated ATOM against 107 industry peers in the Semiconductors & Semiconductor Equipment industry. The financial health of ATOM is average, but there are quite some concerns on its profitability. ATOM is quite expensive at the moment. It does show a decent growth rate.



1

1. Profitability

1.1 Basic Checks

In the past year ATOM has reported negative net income.
ATOM had a negative operating cash flow in the past year.
ATOM had negative earnings in each of the past 5 years.
ATOM had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

Looking at the Return On Assets, with a value of -85.43%, ATOM is doing worse than 90.57% of the companies in the same industry.
ATOM has a worse Return On Equity (-106.44%) than 84.91% of its industry peers.
Industry RankSector Rank
ROA -85.43%
ROE -106.44%
ROIC N/A
ROA(3y)-63.72%
ROA(5y)-63.24%
ROE(3y)-83.38%
ROE(5y)-77.31%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

The Gross Margin of ATOM (89.26%) is better than 99.06% of its industry peers.
In the last couple of years the Gross Margin of ATOM has grown nicely.
The Profit Margin and Operating Margin are not available for ATOM so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 89.26%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.43%
GM growth 5Y18.86%

4

2. Health

2.1 Basic Checks

ATOM does not have a ROIC to compare to the WACC, probably because it is not profitable.
ATOM has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, ATOM has more shares outstanding
ATOM has a better debt/assets ratio than last year.

2.2 Solvency

Based on the Altman-Z score of 1.29, we must say that ATOM is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of 1.29, ATOM is not doing good in the industry: 72.64% of the companies in the same industry are doing better.
ATOM has a Debt/Equity ratio of 0.08. This is a healthy value indicating a solid balance between debt and equity.
ATOM has a Debt to Equity ratio (0.08) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF N/A
Altman-Z 1.29
ROIC/WACCN/A
WACC12.06%

2.3 Liquidity

ATOM has a Current Ratio of 6.78. This indicates that ATOM is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 6.78, ATOM belongs to the top of the industry, outperforming 87.74% of the companies in the same industry.
ATOM has a Quick Ratio of 6.78. This indicates that ATOM is financially healthy and has no problem in meeting its short term obligations.
ATOM has a Quick ratio of 6.78. This is amongst the best in the industry. ATOM outperforms 93.40% of its industry peers.
Industry RankSector Rank
Current Ratio 6.78
Quick Ratio 6.78

6

3. Growth

3.1 Past

The earnings per share for ATOM have decreased by -3.17% in the last year.
ATOM shows a strong growth in Revenue. In the last year, the Revenue has grown by 5580.00%.
ATOM shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 17.08% yearly.
EPS 1Y (TTM)-3.17%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q-11.76%
Revenue 1Y (TTM)5580%
Revenue growth 3Y109.29%
Revenue growth 5Y17.08%
Revenue growth Q2QN/A

3.2 Future

The Earnings Per Share is expected to grow by 19.72% on average over the next years. This is quite good.
ATOM is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 319.52% yearly.
EPS Next Y15.81%
EPS Next 2Y19.72%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year500%
Revenue Next 2Y319.52%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

0

4. Valuation

4.1 Price/Earnings Ratio

ATOM reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year ATOM is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

ATOM's earnings are expected to grow with 19.72% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y19.72%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for ATOM!.
Industry RankSector Rank
Dividend Yield N/A

ATOMERA INC

NASDAQ:ATOM (5/3/2024, 7:00:01 PM)

After market: 4.55 +0.05 (+1.11%)

4.5

+0.05 (+1.12%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap121.00M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -85.43%
ROE -106.44%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 89.26%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.02
Health
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 6.78
Quick Ratio 6.78
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-3.17%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y15.81%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)5580%
Revenue growth 3Y109.29%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y